DOCPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
DOCPHARMA
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€581,444
2024 · €1.2m-€624,842
Equity
€36.6m
2024 · €36.0m+€581,444
Cash
-
not filed
Balance sheet total
€48.2m
2024 · €47.2m+€1.0m
Largest movements
Assets
- Receivables within one year +€1.0m
up €1.0m (+2.2%), from €47.2m to €48.2m
Equity and liabilities
- Profit (loss) carried forward +€581,444
up €581,444 (+1.2%), from -€47.3m to -€46.7m
Income statement
- Financial income -€638,788
down €638,788 (-37.6%), from €1.7m to €1.1m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€1.2m
Provisions
+€1,237
Other operating items
-€8,759
Financial income
-€638,788
Financial charges
+€1,116
Taxes
+€20,352
Result 2025
€581,444
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €47,169,110 | €48,203,405 | +€1.0m | +2.2% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €0 | €0 | = | |
| Furniture and vehicles | 24 | €0 | €0 | = | |
| Financial fixed assets | 28 | €0 | €0 | = | |
| Affiliated companies | 280/1 | €0 | €0 | = | |
| Participating interests | 280 | €0 | €0 | = | |
| Current assets | 29/58 | €47,169,110 | €48,203,405 | +€1.0m | +2.2% |
| Amounts receivable within one year | 40/41 | €47,169,110 | €48,203,405 | +€1.0m | +2.2% |
| Other amounts receivable | 41 | €47,169,110 | €48,203,405 | +€1.0m | +2.2% |
| Total equity and liabilities | 10/49 | €47,169,110 | €48,203,405 | +€1.0m | +2.2% |
| Equity | 10/15 | €35,969,736 | €36,551,180 | +€581,444 | +1.6% |
| Contributions | 10/11 | €83,290,373 | €83,290,373 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€47,320,637 | -€46,739,193 | +€581,444 | +1.2% |
| Provisions and deferred taxes | 16 | €11,186,909 | €11,638,540 | +€451,632 | +4.0% |
| Provisions for liabilities and charges | 160/5 | €11,186,909 | €11,638,540 | +€451,632 | +4.0% |
| Other liabilities and charges | 164/5 | €11,186,909 | €11,638,540 | +€451,632 | +4.0% |
| Amounts payable | 17/49 | €12,465 | €13,685 | +€1,219 | +9.8% |
| Amounts payable within one year | 42/48 | €12,465 | €13,685 | +€1,219 | +9.8% |
| Trade debts | 44 | €12,465 | €13,685 | +€1,219 | +9.8% |
| Suppliers | 440/4 | €12,465 | €13,685 | +€1,219 | +9.8% |
| Other amounts payable | 47/48 | €0 | €0 | = | |
| Operating charges | 60/66A | €469,053 | €476,575 | +€7,522 | +1.6% |
| Services and other goods | 61 | €16,184 | €24,943 | +€8,759 | +54.1% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €452,869 | €451,632 | -€1,237 | -0.3% |
| Operating profit (loss) | 9901 | -€469,053 | -€476,575 | -€7,522 | -1.6% |
| Financial income | 75/76B | €1,697,570 | €1,058,783 | -€638,788 | -37.6% |
| Recurring financial income | 75 | €1,697,570 | €1,058,783 | -€638,788 | -37.6% |
| Income from current assets | 751 | €1,697,570 | €1,058,783 | -€638,788 | -37.6% |
| Other financial income | 752/9 | €0 | €0 | = | |
| Financial charges | 65/66B | €1,880 | €764 | -€1,116 | -59.4% |
| Recurring financial charges | 65 | €1,880 | €764 | -€1,116 | -59.4% |
| Other financial charges | 652/9 | €1,880 | €764 | -€1,116 | -59.4% |
| Profit (loss) for the period before taxes | 9903 | €1,226,638 | €581,444 | -€645,194 | -52.6% |
| Income taxes | 67/77 | €20,352 | - | -€20,352 | |
| Taxes | 670/3 | €20,352 | - | -€20,352 | |
| Profit (loss) for the period | 9904 | €1,206,286 | €581,444 | -€624,842 | -51.8% |
| Profit (loss) for the period to be appropriated | 9905 | €1,206,286 | €581,444 | -€624,842 | -51.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.